Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/72461
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The mechanism of axonal degeneration after perikaryal excitotoxic injury to the retina |
Author: | Bull, N. Chidlow, G. Wood, J. Martin, K. Casson, R. |
Citation: | Experimental Neurology, 2012; 236(1):34-45 |
Publisher: | Academic Press Inc Elsevier Science |
Issue Date: | 2012 |
ISSN: | 0014-4886 1090-2430 |
Statement of Responsibility: | Natalie D. Bull, Glyn Chidlow, John P.M. Wood, Keith R. Martin, Robert J. Casson |
Abstract: | We investigated the mechanism of secondary axonal degeneration after perikaryal excitotoxic injury to retinal ganglion cells (RGCs) by comparing pathological responses in wild-type rats and Wld(s) rats, which display delayed Wallerian degeneration. After perikaryal excitotoxic RGC injury, both types of rats exhibited a spatio-temporal pattern of axonal cytoskeletal degeneration consistent with Wallerian degeneration, which was delayed by up to 4 weeks in Wld(s) rats. Furthermore, RGC somal loss was greater in Wld(s) rats. Microglial response in the anterior visual pathway to injury was attenuated in the Wld(s) rats with lymphocytic infiltration that was relatively reduced; however, immunostaining for major histocompatibility complex class II antigens (OX6) was more pronounced in Wld(s) rats. These data indicate that perikaryal excitotoxic RGC injury causes a secondary Wallerian axonal degeneration, and support the notion of a labile, soma-derived axonal survival factor. |
Keywords: | Excitotoxicity Wallerian Neurodegeneration |
Rights: | Copyright © 2012 Elsevier Inc. All rights reserved. |
DOI: | 10.1016/j.expneurol.2012.03.021 |
Published version: | http://dx.doi.org/10.1016/j.expneurol.2012.03.021 |
Appears in Collections: | Aurora harvest 5 Opthalmology & Visual Sciences publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.